Am J Physiol Cell Physiol Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 295: C1161-C1168, 2008. First published September 3, 2008; doi:10.1152/ajpcell.00139.2008
0363-6143/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
295/5/C1161    most recent
00139.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qiao, J.
Right arrow Articles by Lum, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qiao, J.
Right arrow Articles by Lum, H.

VASCULAR BIOLOGY

Phosphorylation of GTP dissociation inhibitor by PKA negatively regulates RhoA

Jing Qiao,1 Oksana Holian,1 Bao-Shiang Lee,2 Fei Huang,1 Jihang Zhang,1 and Hazel Lum1

1Department of Pharmacology, Rush University Medical Center and 2Research Resources Center, Protein Core Facility, University of Illinois, Chicago, Illinois

Submitted 6 March 2008 ; accepted in final form 30 August 2008

The cAMP-PKA cascade is a recognized signaling pathway important in inhibition of inflammatory injury events such as endothelial permeability and leucocyte trafficking, and a critical target of regulation is believed to be inhibition of Rho proteins. Here, we hypothesize that PKA directly phosphorylates GTP dissociation inhibitor (GDI) to negatively regulate Rho activity. Amino acid analysis of GDI{alpha} showed two potential protein kinase A (PKA) phosphorylation motifs, Ser174 and Thr182. Using in vitro kinase assay and mass spectrometry, we found that the purified PKA catalytic subunit phosphorylated GDI{alpha}-GST fusion protein and PKA motif-containing GDI{alpha} peptide at Ser174, but not Thr182. Transfection of COS-7 cells with mutated full-length GDI{alpha} at Ser174 to Ala174 (GDI{alpha}-Ser174A) abrogated the ability of cAMP to phosphorylate GDI{alpha}. However, mutation of Thr182 to Ala182 (GDI{alpha}-Thr182A) did not abrogate, and cAMP increased phosphorylation of GDI{alpha} to a similar extent as wild-type GDI{alpha} transfectants. The mutant GDI{alpha}-Ser174A, but not GDI{alpha}-Thr182A, was unable to prevent cAMP-mediated inhibition of Rho-dependent serum-response element reporter activity. Furthermore, the mutant GDI{alpha}-Ser174A was unable to prevent the thrombin-induced RhoA activation. Coprecipitation studies indicated that neither mutation of the PKA consensus sites nor phosphorylation alter GDI{alpha} binding with RhoA, suggesting that phosphorylation of Ser174 regulated preformed GDI{alpha}-RhoA complexes. The findings provide strong support that the selective phosphorylation at Ser174 by PKA is a signaling pathway in the negative regulation of RhoA activity and therefore could be a potential protective mechanism for inflammatory injury.

adenosine 3',5'-cyclic monophosphate-dependent protein kinase; protein kinase A consensus phosphorylation sites; single-site mutated GDI{alpha}



Address for reprint requests and other correspondence: Hazel Lum, Dept. of Pharmacology, Rush Univ. Medical Center, 1735 W. Harrison St., Cohn Research Bldg.; Rm 416, Chicago, IL 60612 (e-mail: hlum{at}rush.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.